Your browser doesn't support javascript.
loading
Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death.
Selvin, Tove; Berglund, Malin; Lenhammar, Lena; Jarvius, Malin; Nygren, Peter; Fryknäs, Mårten; Larsson, Rolf; Andersson, Claes R.
Afiliação
  • Selvin T; Department of Medical Sciences, Division of Cancer Pharmacology and Computational Medicine, Uppsala University, SE-75185, Uppsala, Sweden. tove.selvin@medsci.uu.se.
  • Berglund M; Department of Medical Sciences, Division of Cancer Pharmacology and Computational Medicine, Uppsala University, SE-75185, Uppsala, Sweden.
  • Lenhammar L; Department of Medical Sciences, Division of Cancer Pharmacology and Computational Medicine, Uppsala University, SE-75185, Uppsala, Sweden.
  • Jarvius M; Department of Medical Sciences, Division of Cancer Pharmacology and Computational Medicine, Uppsala University, SE-75185, Uppsala, Sweden.
  • Nygren P; Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, Box 591, SE-751 24, Uppsala, Sweden.
  • Fryknäs M; Department of Immunology, Genetics and Pathology, Uppsala University, SE-75185, Rudbecklaboratoriet, Uppsala, Sweden.
  • Larsson R; Department of Medical Sciences, Division of Cancer Pharmacology and Computational Medicine, Uppsala University, SE-75185, Uppsala, Sweden.
  • Andersson CR; Department of Medical Sciences, Division of Cancer Pharmacology and Computational Medicine, Uppsala University, SE-75185, Uppsala, Sweden.
BMC Cancer ; 23(1): 164, 2023 Feb 17.
Article em En | MEDLINE | ID: mdl-36803614

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Neoplasias Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Neoplasias Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia